D. Angus and T. Van-der-poll, Severe Sepsis and Septic Shock, New England Journal of Medicine, vol.369, issue.9, p.2063, 2013.
DOI : 10.1056/NEJMra1208623

F. Mayr, S. Yende, and D. Angus, Epidemiology of severe sepsis, Virulence, vol.38, issue.1, pp.4-11, 2014.
DOI : 10.1164/rccm.200712-1777OC

R. Dellinger, M. Levy, A. Rhodes, D. Annane, H. Gerlach et al., Surviving Sepsis Campaign, Critical Care Medicine, vol.41, issue.2, pp.165-228, 2012.
DOI : 10.1097/CCM.0b013e31827e83af

S. Liu and A. Malik, NF-??B activation as a pathological mechanism of septic shock and inflammation, AJP: Lung Cellular and Molecular Physiology, vol.290, issue.4, pp.622-667, 2006.
DOI : 10.1152/ajplung.00477.2005

G. Bonizzi and K. M. , The two NF-??B activation pathways and their role in innate and adaptive immunity, Trends in Immunology, vol.25, issue.6, pp.280-288, 2004.
DOI : 10.1016/j.it.2004.03.008

R. Ryseck, J. Novotny, and R. Bravo, Characterization of elements determining the dimerization properties of RelB and p50., Molecular and Cellular Biology, vol.15, issue.6, pp.3100-3109, 1995.
DOI : 10.1128/MCB.15.6.3100

F. Arnalich, E. Garcia?palomero, J. Lopez, M. Jimenez, R. Madero et al., Predictive Value of Nuclear Factor kappa B Activity and Plasma Cytokine Levels in Patients with Sepsis, Infection and Immunity, vol.68, issue.4, pp.1942-1947, 2000.
DOI : 10.1128/IAI.68.4.1942-1945.2000

H. Bohrer, F. Qiu, T. Zimmermann, Y. Zhang, T. Jllmer et al., Role of NFkappaB in the mortality of sepsis., Journal of Clinical Investigation, vol.100, issue.5, pp.972-85, 1997.
DOI : 10.1172/JCI119648

G. Grigoriadis, Y. Zhan, R. Grumont, D. Metcalf, E. Handman et al., The Rel subunit of NF?kappaB?like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations, EMBO J, vol.15, pp.7099-107, 1996.

N. Mason, J. Aliberti, J. Caamano, H. Liou, and C. Hunter, Cutting Edge: Identification of c-Rel-Dependent and -Independent Pathways of IL-12 Production During Infectious and Inflammatory Stimuli, The Journal of Immunology, vol.168, issue.6, pp.2590-2594, 2002.
DOI : 10.4049/jimmunol.168.6.2590

L. Harling?mcnabb, G. Deliyannis, D. Jackson, S. Gerondakis, G. Grigoriadis et al., Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response, International Immunology, vol.11, issue.9, pp.1431-1440, 1999.
DOI : 10.1093/intimm/11.9.1431

D. Carrasco, J. Cheng, A. Lewin, G. Warr, H. Yang et al., Multiple Hemopoietic Defects and Lymphoid Hyperplasia in Mice Lacking the Transcriptional Activation Domain of the c-Rel Protein, The Journal of Experimental Medicine, vol.6, issue.7, pp.973-84, 1998.
DOI : 10.1084/jem.186.7.999

K. Bunting, S. Rao, K. Hardy, D. Woltring, G. Denyer et al., Genome-Wide Analysis of Gene Expression in T Cells to Identify Targets of the NF-??B Transcription Factor c-Rel, The Journal of Immunology, vol.178, issue.11, pp.7097-109, 2007.
DOI : 10.4049/jimmunol.178.11.7097

H. Liou and K. Smith, The roles of c-rel and interleukin-2 in tolerance: a molecular explanation of self???nonself discrimination, Immunology and Cell Biology, vol.177, issue.1, pp.27-32, 2011.
DOI : 10.1074/jbc.M109.052712

J. Tumang, C. Hsia, W. Tian, J. Bromberg, and H. Liou, IL-6 rescues the hyporesponsiveness of c-Rel deficient B cells independent of Bcl-xL, Mcl-1, and Bcl-2, Cellular Immunology, vol.217, issue.1-2, pp.47-57, 2002.
DOI : 10.1016/S0008-8749(02)00513-0

H. Shindo, K. Yasui, K. Yamamoto, K. Honma, K. Yui et al., Interferon regulatory factor-4 activates IL-2 and IL-4 promoters in cooperation with c-Rel, Cytokine, vol.56, issue.3, pp.564-72, 2011.
DOI : 10.1016/j.cyto.2011.08.014

G. Chen, K. Hardy, K. Bunting, S. Daley, L. Ma et al., Regulation of the IL-21 Gene by the NF-??B Transcription Factor c-Rel, The Journal of Immunology, vol.185, issue.4, pp.2350-2359, 2010.
DOI : 10.4049/jimmunol.1000317

R. Siegel, J. Eskdale, and G. Gallagher, Regulation of IFN-??1 Promoter Activity (IFN-??1/IL-29) in Human Airway Epithelial Cells, The Journal of Immunology, vol.187, issue.11, pp.5636-5680, 2011.
DOI : 10.4049/jimmunol.1003988

J. Siednienko, A. Maratha, S. Yang, M. Mitkiewicz, S. Miggin et al., Nuclear Factor ??B Subunits RelB and cRel Negatively Regulate Toll-like Receptor 3-mediated ??-Interferon Production via Induction of Transcriptional Repressor Protein YY1, Journal of Biological Chemistry, vol.286, issue.52, pp.44750-63, 2011.
DOI : 10.1074/jbc.M111.250894

E. Courtine, F. Pene, N. Cagnard, J. Toubiana, C. Fitting et al., Critical Role of cRel Subunit of NF-??B in Sepsis Survival, Infection and Immunity, vol.79, issue.5, pp.1848-54, 2011.
DOI : 10.1128/IAI.00021-11

T. Gilmore and S. Gerondakis, The c-Rel Transcription Factor in Development and Disease, Genes & Cancer, vol.2, issue.7, pp.695-711, 2011.
DOI : 10.1177/1947601911421925

M. Wurfel, A. Gordon, T. Holden, F. Radella, J. Strout et al., Toll-like Receptor 1 Polymorphisms Affect Innate Immune Responses and Outcomes in Sepsis, American Journal of Respiratory and Critical Care Medicine, vol.178, issue.7, pp.710-730, 2008.
DOI : 10.1164/rccm.200803-462OC

T. Hawn, A. Verbon, K. Lettinga, L. Zhao, S. Li et al., A Common Dominant TLR5 Stop Codon Polymorphism Abolishes Flagellin Signaling and Is Associated with Susceptibility to Legionnaires' Disease, The Journal of Experimental Medicine, vol.66, issue.10, pp.1563-72, 2003.
DOI : 10.1016/S1074-7613(01)00201-1

E. Lorenz, J. Mira, K. Frees, and D. Schwartz, Relevance of Mutations in the TLR4 Receptor in Patients With Gram-Negative Septic Shock, Archives of Internal Medicine, vol.162, issue.9, pp.1028-1060, 2002.
DOI : 10.1001/archinte.162.9.1028

C. Khor, S. Chapman, F. Vannberg, A. Dunne, C. Murphy et al., A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis, Nature Genetics, vol.65, issue.4, pp.523-531, 2007.
DOI : 10.1038/ng1976

J. Toubiana, E. Courtine, F. Pene, V. Viallon, P. Asfar et al., IRAK1 functional genetic variant affects severity of septic shock*, Critical Care Medicine, vol.38, issue.12, pp.2287-94, 2010.
DOI : 10.1097/CCM.0b013e3181f9f9c7

J. Arcaroli, E. Silva, J. Maloney, Q. He, D. Svetkauskaite et al., Variant IRAK-1 Haplotype Is Associated with Increased Nuclear Factor?????B Activation and Worse Outcomes in Sepsis, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.12, pp.1335-1376, 2006.
DOI : 10.1164/rccm.200603-341OC

S. Chapman, C. Khor, F. Vannberg, A. Frodsham, A. Walley et al., I??B Genetic Polymorphisms and Invasive Pneumococcal Disease, American Journal of Respiratory and Critical Care Medicine, vol.176, issue.2, pp.181-188, 2007.
DOI : 10.1164/rccm.200702-169OC

S. Thair, K. Walley, T. Nakada, M. Mcconechy, J. Boyd et al., A Single Nucleotide Polymorphism in NF-??B Inducing Kinase Is Associated with Mortality in Septic Shock, The Journal of Immunology, vol.186, issue.4, pp.2321-2329, 2011.
DOI : 10.4049/jimmunol.1002864

R. Dellinger, J. Carlet, H. Masur, H. Gerlach, C. T. Cohen et al., Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock, Critical Care Medicine, vol.32, issue.3, pp.858-73, 2004.
DOI : 10.1097/01.CCM.0000117317.18092.E4

R. Bone, R. Balk, F. Cerra, R. Dellinger, A. Fein et al., Defini? tions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, The ACCP/SCCM Consensus Conference Committee, pp.1644-55, 1992.

C. Brun?buisson, F. Doyon, J. Carlet, P. Dellamonica, F. Gouin et al., Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis, JAMA: The Journal of the American Medical Association, vol.274, issue.12, pp.968-74, 1995.
DOI : 10.1001/jama.274.12.968

D. Schoenfeld and G. Bernard, Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome, Critical Care Medicine, vol.30, issue.8, pp.1772-1779, 2002.
DOI : 10.1097/00003246-200208000-00016

J. Li and J. L. , Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix, Heredity, vol.62, issue.3, pp.221-228, 2005.
DOI : 10.1002/1098-2272(200012)19:4<323::AID-GEPI4>3.0.CO;2-5

A. Hattersley and M. Mccarthy, What makes a good genetic association study?, The Lancet, vol.366, issue.9493, pp.1315-1338, 2005.
DOI : 10.1016/S0140-6736(05)67531-9

S. Eyre, A. Hinks, E. Flynn, P. Martin, A. Wilson et al., Confirmation of association of the REL locus with rheumatoid arthritis susceptibility in the UK population, Annals of the Rheumatic Diseases, vol.69, issue.8, pp.1572-1575, 2010.
DOI : 10.1136/ard.2009.122887

P. Gregersen, C. Amos, A. Lee, Y. Lu, E. Remmers et al., REL, encoding a member of the NF-??B family of transcription factors, is a newly defined risk locus for rheumatoid arthritis, Nature Genetics, vol.81, issue.7, pp.820-823, 2009.
DOI : 10.1002/art.10726

E. Stahl, S. Raychaudhuri, E. Remmers, G. Xie, S. Eyre et al., Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci, Nature Genetics, vol.447, issue.6, pp.508-522, 2010.
DOI : 10.1038/ng.468

F. Ali, A. Barton, R. Smith, J. Bowes, E. Flynn et al., gene, British Journal of Dermatology, vol.132, issue.4, pp.864-870, 2013.
DOI : 10.1111/bjd.12106

URL : https://hal.archives-ouvertes.fr/inserm-00465889

A. Zhernakova, E. Festen, L. Franke, G. Trynka, C. Van-diemen et al., Genetic Analysis of Innate Immunity in Crohn's Disease and Ulcerative Colitis Identifies Two Susceptibility Loci Harboring CARD9 and IL18RAP, The American Journal of Human Genetics, vol.82, issue.5, pp.1202-1212, 2008.
DOI : 10.1016/j.ajhg.2008.03.016

G. Trynka, A. Zhernakova, J. Romanos, L. Franke, K. Hunt et al., Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-??B signalling, Gut, vol.58, issue.8, pp.1078-83, 2009.
DOI : 10.1136/gut.2008.169052

V. Izzo, M. Pinelli, N. Tinto, M. Esposito, A. Cola et al., Improving the Estimation of Celiac Disease Sibling Risk by Non-HLA Genes, PLoS ONE, vol.57, issue.11, p.26920, 2011.
DOI : 10.1371/journal.pone.0026920.s004

M. Janse, L. Lamberts, L. Franke, S. Raychaudhuri, E. Ellinghaus et al., Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9, Hepatology, vol.92, issue.6, pp.1977-85, 2011.
DOI : 10.1002/hep.24307

A. Strange, F. Capon, C. Spencer, and J. Knight, A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1, Nature Genetics, vol.447, issue.11, pp.985-90, 2010.
DOI : 10.1086/319501

D. Mcgovern, A. Gardet, L. Torkvist, P. Goyette, J. Essers et al., Genome-wide association identifies multiple ulcerative colitis susceptibility loci, Nature Genetics, vol.275, issue.4, pp.332-339, 2010.
DOI : 10.1038/ng.549

M. Silverberg, J. Cho, J. Rioux, D. Mcgovern, J. Wu et al., Ulcerative colitis???risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study, Nature Genetics, vol.118, issue.2, pp.216-236, 2009.
DOI : 10.1126/science.1117196

V. Enciso?mora, P. Broderick, Y. Ma, R. Jarrett, H. Hjalgrim et al., A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3), Nature Genetics, vol.14, issue.12, pp.1126-1156, 2010.
DOI : 10.1002/sim.4780040112

N. Hotta, T. Ichiyama, M. Shiraishi, T. Takekawa, T. Matsubara et al., Nuclear factor-??B activation in peripheral blood mononuclear cells in children with sepsis, Critical Care Medicine, vol.35, issue.10, pp.2395-401, 2007.
DOI : 10.1097/01.CCM.0000284502.38701.E6

I. Campbell, S. Gerondakis, O. Donnell, K. Wicks, and I. , Distinct roles for the NF-??B1 (p50) and c-Rel transcription factors in inflammatory arthritis, Journal of Clinical Investigation, vol.105, issue.12, pp.1799-806, 2000.
DOI : 10.1172/JCI8298

B. Hilliard, N. Mason, L. Xu, J. Sun, S. Lamhamedi?cherradi et al., Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation, Journal of Clinical Investigation, vol.110, issue.6, pp.843-50, 2002.
DOI : 10.1172/JCI0215254

A. Rautanen, T. Mills, A. Gordon, P. Hutton, M. Steffens et al., Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study, The Lancet Respiratory Medicine, vol.3, issue.1, pp.53-60, 2015.
DOI : 10.1016/S2213-2600(14)70290-5

M. Karin, Y. Yamamoto, and Q. Wang, The IKK NF-??B system: a treasure trove for drug development, Nature Reviews Drug Discovery, vol.3, issue.1, pp.17-26, 2004.
DOI : 10.1038/nrd1279

Y. Shono, A. Tuckett, S. Ouk, H. Liou, G. Altan?bonnet et al., A Small-Molecule c-Rel Inhibitor Reduces Alloactivation of T Cells without Compromising Antitumor Activity, Cancer Discovery, vol.4, issue.5, pp.578-91, 2014.
DOI : 10.1158/2159-8290.CD-13-0585